Stockreport

Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market [Financial Post (Toronto,...

Elevai Labs, Inc.  (ELAB) 
PDF NEWPORT BEACH, Calif., March 18, 2024 (GLOBE NEWSWIRE) — ELEVAI LABS, INC., (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skin care, is [Read more]